CyberKnife stereotactic ablative radiotherapy (SABR) in patients with non-small cell lung cancer ( NSCLC)

被引:0
|
作者
Leschenko, Y. [1 ]
Chebotareva, T. [1 ]
Spizhenko, N. [1 ]
Fedusenko, A. [1 ]
Sharaevskiy, O. [1 ]
Buryk, V. [1 ]
机构
[1] Cyber Knife, Cyber Clin Spizhenko, Kapitanivka, Kyiv Region, Ukraine
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EP-1155
引用
收藏
页码:S39 / S39
页数:1
相关论文
共 50 条
  • [31] To SABR or Not to SABR? Indications and Contraindications for Stereotactic Ablative Radiotherapy in the Treatment of Early-Stage, Oligometastatic, or Oligoprogressive Non-Small Cell Lung Cancer
    Shultz, David Benjamin
    Diehn, Maximilian
    Loo, Billy W., Jr.
    SEMINARS IN RADIATION ONCOLOGY, 2015, 25 (02) : 78 - 86
  • [32] Role of consolidative stereotactic ablative radiotherapy in patients with oligometastatic non-small cell lung cancer
    Ricardi, Umberto
    Levra, Niccolo Giaj
    Badellino, Serena
    Alongi, Filippo
    JOURNAL OF THORACIC DISEASE, 2017, 9 (08) : 2235 - 2237
  • [33] Surgery versus stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung cancer: less is not more
    White, Abby
    Swanson, Scott J.
    JOURNAL OF THORACIC DISEASE, 2016, 8 : S399 - S405
  • [34] Oligometastatic non-small cell lung cancer: a narrative review of stereotactic ablative radiotherapy
    Dohopolski, Michael
    Iyengar, Puneeth
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (05) : 5944 - 5953
  • [35] Non-small Cell Lung Cancer Stereotactic ablative Radiotherapy vs. Lobectomy
    Passlick, Bernward
    ZENTRALBLATT FUR CHIRURGIE, 2016, 141 (03): : 237 - 238
  • [36] SARON: Stereotactic Ablative Radiotherapy for Oligometastatic Non-small cell lung cancer (NSCLC): a randomised phase III trial
    McDonald, F.
    Mak, K. M.
    Teague, J.
    Landau, D.
    Hanna, G.
    Farrelly, L.
    Counsell, N.
    LUNG CANCER, 2020, 139 : S91 - S91
  • [37] Stereotactic ablative radiotherapy (SABR) in non-surgical non small cell lung cancer: Effects on respiratory function
    Ferrero, Cinzia
    Levra, Matteo Giaj
    Rapetti, Simonetta
    Moretto, Francesco
    Ricardi, Umberto
    Filippi, Andrea
    Ciacco, Claudio
    Guglielmo, Marco
    Focaraccio, Luana
    Novella, Silvia
    Torchio, Roberto
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [38] Stereotactic ablative radiotherapy (SABR) for early stage, medically inoperable non-small cell lung cancer (NSCLC): clinical outcome of 5 years of experience at the Oxford Cancer Centre
    Pascal, L.
    Bull, L.
    Ajzensztejn, D.
    Higgins, G.
    Stuart, R.
    Panakis, N.
    LUNG CANCER, 2018, 115 : S61 - S61
  • [39] Stereotactic ablative body radiotherapy (SABR) for early stage non-small cell lung cancer (NSCLC) at a tertiary referral centre results of the first year of treatment at Birmingham
    Stevenson, R.
    Price, L.
    Webster, G.
    Brennan, M.
    Stange, D.
    Wingate, E.
    Biard, K.
    Ghafoor, Q.
    LUNG CANCER, 2015, 87 : S47 - S47
  • [40] Stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer: Comparing survival outcomes in adenocarcinoma and squamous cell carcinoma
    Abel, Stephen
    Hasan, Shaakir
    White, Richard
    Schumacher, Lana
    Finley, Gene
    Colonias, Athanasios
    Wegner, Rodney E.
    LUNG CANCER, 2019, 128 : 127 - 133